-
Watson-Marlow introduces DriveSure® OEM pump solution at ACHEMA 2024
Falmouth UK, 14th May 2024 / Sciad Newswire / Watson-Marlow Fluid Technology Solutions (WMFTS) will showcase its recently launched DriveSure® panel mount pumps along with other products for life sciences companies at ACHEMA 2024 in Germany (June 10-14). Visitors to Booth C48 in Hall 3.1 at Messe Frankfurt GmbH will learn how the cool, quiet…
-
Watson-Marlow advances its OEM panel mount solution DriveSure with latest technology
Falmouth, UK, 30th April 2024 / Sciad Newswire / Watson-Marlow Fluid Technology Solutions (WMFTS) has advanced DriveSure® with the latest technology to offer a complete peristaltic panel mount pump solution for original equipment manufacturers (OEMs). With Industrial Ethernet capability, DriveSure simplifies integration into advanced distributed control systems and offers end-users remote monitoring and control. The…
-
Paul Coates joins the SCIAD team as a Web Developer
After working with us for seven years as a freelancer, Sciad is excited to welcome Paul Coates as a member of our team. We’ve interviewed him about his journey into web development, what makes him a great web developer and his advice for companies looking to set up or refresh their own website. How did…
-
Watson-Marlow to showcase latest chemical metering and dosing pump for higher flows at Water Equipment Show
Falmouth, UK, 24th April 2024 / Sciad Newswire / Watson-Marlow Fluid Technology Solutions (WMFTS), a leader in peristaltic pumps and associated fluid path technologies, will showcase its diverse product range at the Water Equipment Show hosted in Telford, UK, on 16th May. WMFTS will exhibit its precision-engineered peristaltic pumps and critical fluid path technologies for…
-
Watson-Marlow Fluid Technology Solutions launches WMArchitect single-use solutions to optimise biopharmaceutical fluid management
Falmouth, UK, 15th April 2023 / Sciad Newswire / Watson-Marlow Fluid Technology Solutions (WMFTS) has launched WMArchitectTM single-use solutions to offer a wide range of biopharmaceutical fluid management innovations from a single, secure supplier. The flexible, single-use solutions range has been developed by building on years of experience including the predecessor brands of puresu® and asepticsu®, and is designed to streamline…
-
New study explores how Switzerland can maintain its leading position in life science innovation
London, UK, 2nd April 2024 / Sciad / The RSA Group, a leading life sciences executive search firm, has published the latest of its Talent Equity Reports: “Sustaining a winning position” – an analysis of how Switzerland can continue to lead the life sciences sector in a shifting global market. The new report features interviews…
-
Visit Watson-Marlow Fluid Technology Solutions at booth 3521 during INTERPHEX 2024 for exclusive technology previews and insights
Devens, MA, USA, 25th March 2024 / Sciad / Watson-Marlow Fluid Technology Solutions (WMFTS) will preview two new technologies at booth 3521 during INTERPHEX 2024, 16-18th April 2024, Javits Center, NYC, USA. The new solutions further expand WMFTS’s range of comprehensive fluid path technologies and have been developed to provide optimal precision and control for…
-
Darling Ingredients’ Health Brand Rousselot Announces Online Access to Research- and Technical-Grade X-Pure Gelatins through BIO INX
Irving, Texas, US, 13th March 2024 / Sciad Newswire / Darling Ingredients’ health brand Rousselot, a global leader in gelatin- and collagen-based solutions, announced today that its high-quality, research- and technical-grade gelatins are now available for online purchase in Canada, Europe, South Korea and the U.S. through BIO INX, a pioneering developer and distributor of…
-
Celebrating International Women’s Day: A Q&A with Maria Patey
A Q&A with Sciad’s Managing Partner, Maria Patey on International Women’s Day. What do you consider your strengths and proudest achievements in your career? Creativity, Resilience, Intuition; I trust my intuition – and when it comes to a crunch point, I go with my gut, unless there’s a clear reason to pause and re-consider. If…
-
Neobe Therapeutics raises over $2m for synthetic biology enabled tumour microenvironment remodelling
STEVENAGE, UK, 29 February 2024: Neobe Therapeutics, a pioneering synthetic biology startup at the forefront of immuno-oncology innovation, is thrilled to announce the successful closure of a $2.34M financing round. This significant financial milestone was achieved with the support of new investors Pioneer Group and 2048 Ventures, alongside existing backers Deep Science Ventures*, Cancer Research…